Sanofi's Merial acquires animal health division of Dosch

Drugmaker Sanofi Friday said its animal health division Merial has completed of the animal health division of Dosch Pharmaceuticals to enter India's growing animal health market.

The signing of a binding agreement, leading up to the acquisition, was announced in December last year.

Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition, a company release said here.

Dosch, an India-based diversified pharmaceutical company, is a manufacturer of veterinary pharmaceuticals and exporter of bulk drugs and formulations.

The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch's 86 animal health products and 50 brands for ruminants, poultry and companion animals.

image
Business Standard
177 22
Business Standard

Sanofi's Merial acquires animal health division of Dosch

IANS  |  Kolkata 



Drugmaker Sanofi Friday said its animal health division Merial has completed of the animal health division of Dosch Pharmaceuticals to enter India's growing animal health market.

The signing of a binding agreement, leading up to the acquisition, was announced in December last year.

Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition, a company release said here.

Dosch, an India-based diversified pharmaceutical company, is a manufacturer of veterinary pharmaceuticals and exporter of bulk drugs and formulations.

The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch's 86 animal health products and 50 brands for ruminants, poultry and companion animals.

RECOMMENDED FOR YOU

Sanofi's Merial acquires animal health division of Dosch

Drugmaker Sanofi Friday said its animal health division Merial has completed acquisition of the animal health division of Dosch Pharmaceuticals to enter India's growing animal health market.

Drugmaker Sanofi Friday said its animal health division Merial has completed of the animal health division of Dosch Pharmaceuticals to enter India's growing animal health market.

The signing of a binding agreement, leading up to the acquisition, was announced in December last year.

Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition, a company release said here.

Dosch, an India-based diversified pharmaceutical company, is a manufacturer of veterinary pharmaceuticals and exporter of bulk drugs and formulations.

The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch's 86 animal health products and 50 brands for ruminants, poultry and companion animals.

image
Business Standard
177 22

More News

  • Signs of realty revival ahead of festive season Signs of realty revival ahead of festive season
  • Amit Chandra Bain Capital's Amit Chandra joins Tata Sons board
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard